A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia

NCT00550680 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Renal Anemia

Interventions

DRUG: Methoxy polyethylene glycol-epoetin beta

Sponsor

Hoffmann-La Roche